DE60111254D1 - Verwendung von pde5 inhibitoren zur behandlung vorzeitiger ejakulation - Google Patents

Verwendung von pde5 inhibitoren zur behandlung vorzeitiger ejakulation

Info

Publication number
DE60111254D1
DE60111254D1 DE60111254T DE60111254T DE60111254D1 DE 60111254 D1 DE60111254 D1 DE 60111254D1 DE 60111254 T DE60111254 T DE 60111254T DE 60111254 T DE60111254 T DE 60111254T DE 60111254 D1 DE60111254 D1 DE 60111254D1
Authority
DE
Germany
Prior art keywords
treatment
ejaculation
previous
pde5 inhibitors
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60111254T
Other languages
English (en)
Other versions
DE60111254T2 (de
Inventor
Mitradev Boolell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of DE60111254D1 publication Critical patent/DE60111254D1/de
Application granted granted Critical
Publication of DE60111254T2 publication Critical patent/DE60111254T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
DE60111254T 2000-11-20 2001-11-19 Verwendung von pde5 inhibitoren zur behandlung vorzeitiger ejakulation Expired - Fee Related DE60111254T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0028245.9A GB0028245D0 (en) 2000-11-20 2000-11-20 New therapeutic use
GB0028245 2000-11-20
PCT/IB2001/002180 WO2002040027A1 (en) 2000-11-20 2001-11-19 Treatment of premature ejaculation

Publications (2)

Publication Number Publication Date
DE60111254D1 true DE60111254D1 (de) 2005-07-07
DE60111254T2 DE60111254T2 (de) 2006-05-04

Family

ID=9903491

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60111254T Expired - Fee Related DE60111254T2 (de) 2000-11-20 2001-11-19 Verwendung von pde5 inhibitoren zur behandlung vorzeitiger ejakulation

Country Status (21)

Country Link
EP (1) EP1335730B1 (de)
JP (1) JP2004520279A (de)
KR (1) KR100595807B1 (de)
CN (1) CN1474692A (de)
AT (1) ATE296631T1 (de)
AU (2) AU2002215149B2 (de)
BR (1) BR0115413A (de)
CA (1) CA2429114C (de)
DE (1) DE60111254T2 (de)
ES (1) ES2240537T3 (de)
GB (1) GB0028245D0 (de)
HU (1) HUP0301915A3 (de)
IL (1) IL155521A0 (de)
MX (1) MXPA03003586A (de)
MY (1) MY131573A (de)
NZ (1) NZ525167A (de)
PL (1) PL362058A1 (de)
PT (1) PT1335730E (de)
TW (1) TWI280132B (de)
WO (1) WO2002040027A1 (de)
ZA (1) ZA200302947B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6403597B1 (en) * 1997-10-28 2002-06-11 Vivus, Inc. Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation
AU2003903597A0 (en) * 2003-07-11 2003-07-24 Jakov Vaisman Treatment of premature ejaculation
AT512084A1 (de) 2011-10-20 2013-05-15 Univ Wien Tech Diazabicyclo- und diazaspiro-alkanderivate als phosphodiesterase-5 inhibitoren
EP3646871A1 (de) * 2018-10-30 2020-05-06 SEROJAC PME Handels GmbH Behandlung und prävention von vorzeitiger ejakulation
CN111297869A (zh) * 2020-04-23 2020-06-19 白文智 一种用于治疗早泄和勃起功能障碍的复方制剂

Also Published As

Publication number Publication date
MXPA03003586A (es) 2003-07-14
PT1335730E (pt) 2005-09-30
HUP0301915A3 (en) 2007-03-28
ATE296631T1 (de) 2005-06-15
TWI280132B (en) 2007-05-01
JP2004520279A (ja) 2004-07-08
EP1335730B1 (de) 2005-06-01
MY131573A (en) 2007-08-30
IL155521A0 (en) 2003-11-23
KR20030048476A (ko) 2003-06-19
BR0115413A (pt) 2003-10-07
CA2429114A1 (en) 2002-05-23
ZA200302947B (en) 2004-04-28
PL362058A1 (en) 2004-10-18
GB0028245D0 (en) 2001-01-03
CN1474692A (zh) 2004-02-11
EP1335730A1 (de) 2003-08-20
ES2240537T3 (es) 2005-10-16
WO2002040027A1 (en) 2002-05-23
KR100595807B1 (ko) 2006-07-03
NZ525167A (en) 2005-02-25
AU1514902A (en) 2002-05-27
AU2002215149B2 (en) 2006-04-06
CA2429114C (en) 2007-09-11
DE60111254T2 (de) 2006-05-04
HUP0301915A2 (hu) 2003-09-29

Similar Documents

Publication Publication Date Title
CY1105390T1 (el) Θepαπευτικη αγωγη της πνευμονικης υπερτασης
DE69911448D1 (de) Pyrazolopyrimidinone, cgmp pde5 inhibitoren, zur behandlung von sexuellen funktionsstörungen
CY1110784T1 (el) Ιατρικη χρηση της τετρα-υδροτριαζολο[4,3-α]πυραζινης
TR200200989T2 (tr) Farmasötik açıdan aktif bileşikler.
DE69925970D1 (de) Pyrazolopyrimidinone cGMP PDE5 Inhibitoren zur Behandlung der sexuellen Dysfunktion
ATE283856T1 (de) Zyklische guanosine 3',5'-monophosphate phosphodiesterase inhibitoren
CA2323839A1 (en) Treatment of neuropathy
TR200003039T2 (tr) Seksüel fonksiyon bozukluklarının tedavisi için pirazolopirimidinon cGMP PDE5 inhibitörleri
MXPA04003668A (es) Inhibidores de fosfodiesteresa de tipo 4 y usos de los mismos.
NO20055941L (no) Anvendelse av en sammensetning omfattende en PDE4-inhibitor og en PDE5-inhibitor
DE69811645D1 (de) Phtalazinonen
PA8552501A1 (es) 1-alquil o 1-cicloalquil-triazolo[4,3-a]quinazolin-5-onas como inhibidoras de fosfodiesterasa
MY133995A (en) 6-phenylpyrrolopyrimidinedione derivatives
BR0307410A (pt) Uso de inibidores de pde5 no tratamento da cicatrização e fibrose
DE60108068D1 (de) Behandlung diabetischer ulcera
DE60111254D1 (de) Verwendung von pde5 inhibitoren zur behandlung vorzeitiger ejakulation
MY127989A (en) Treatment of neuropathy
MXPA03010451A (es) Nuevos metodos para el tratamiento y prevencion del dolor.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee